Malhi G, Mann J, London. England). 2018;392(10161):2299–312.

Google Scholar 

Avenevoli S, Swendsen J, He J, Burstein M, Merikangas K. Major depression in the national comorbidity survey-adolescent supplement: prevalence, correlates, and treatment. J Am Acad Child Adolesc Psychiatry. 2015;54(1):37–e442.

Article  PubMed  Google Scholar 

Cox G, Hetrick S. Psychosocial interventions for self-harm, suicidal ideation and suicide attempt in children and young people: what? How? Who? And where? Evid Based Ment Health. 2017;20(2):35–40.

Article  PubMed  PubMed Central  Google Scholar 

Izaki Y. Depression among adolescents: clinical features and interventions. J Med Investig. 2021;68(12):22–8.

Article  Google Scholar 

Zhou X, Teng T, Zhang Y, Del Giovane C, et al. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2020;7(7):581–601.

Article  PubMed  PubMed Central  Google Scholar 

Cuijpers P, Karyotaki E, Eckshtain D, Ng M, et al. Psychotherapy for Depression Across different age groups: a systematic review and Meta-analysis. JAMA Psychiatry. 2020;77(7):694–702.

Article  PubMed  PubMed Central  Google Scholar 

Bahji A, Forth E, Hargreaves T, Harkness K. Genetic markers of the stress generation model: a systematic review. Psychiatry Res. 2021;304:114139.

Article  CAS  PubMed  Google Scholar 

Murack M, Chandrasegaram R, Smith K, Ah-Yen E, et al. Chronic sleep disruption induces depression-like behavior in adolescent male and female mice and sensitization of the hypothalamic-pituitary-adrenal axis in adolescent female mice. Behav Brain Res. 2021;399:113001.

Article  CAS  PubMed  Google Scholar 

Boeschoten R, Braamse A, Beekman A, Cuijpers P, et al. Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci. 2017;372:331–41.

Article  PubMed  Google Scholar 

Landrum K, Pence B, Gaynes B, Dussault J, et al. The cross-sectional association of stressful life events with depression severity among patients with hypertension and diabetes in Malawi. PLoS ONE. 2022;17(12):e0279619.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raison C, Rutherford R, Woolwine B, Shuo C, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70(1):31–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mao R, Zhang C, Chen J, Zhao G, et al. Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression. J Affect Disord. 2018;237:65–72.

Article  CAS  PubMed  Google Scholar 

Hannestad J, DellaGioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology: Official Publication Am Coll Neuropsychopharmacol. 2011;36(12):2452–9.

Article  CAS  Google Scholar 

Gasparini A, Callegari C, Lucca G, Bellini A, et al. Inflammatory biomarker and response to antidepressant in major depressive disorder: a systematic review and Meta-analysis. Psychopharmacol Bull. 2022;52(1):36–52.

CAS  PubMed  PubMed Central  Google Scholar 

Andrade W, Zamboni D. Inflammasome-dependent mechanisms involved in sensing and restriction of bacterial replication. Curr Issues Mol Biol. 2018;25:99–132.

Article  PubMed  Google Scholar 

Man S, Kanneganti T. Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat Rev Immunol. 2016;16(1):7–21.

Article  CAS  PubMed  Google Scholar 

Kaufmann FN, Costa AP, Ghisleni G, Diaz AP, et al. NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings. Brain Behav Immun. 2017;64:367–83.

Article  CAS  PubMed  Google Scholar 

Taene A, Khalili-Tanha G, Esmaeili A, Mobasheri L, Kooshkaki O, Jafari S, et al. The Association of Major Depressive Disorder with activation of NLRP3 inflammasome, lipid peroxidation, and total antioxidant capacity. J Mol Neuroscience: MN. 2020;70(1):65–70.

Article  CAS  Google Scholar 

Li ZQ, Yan ZY, Lan FJ, Dong YQ, Xiong Y. Suppression of NLRP3 inflammasome attenuates stress-induced depression-like behavior in NLGN3-deficient mice. Biochem Biophys Res Commun. 2018;501(4):933–40.

Article  CAS  PubMed  Google Scholar 

Alcocer-Gómez E, de Miguel M, Casas-Barquero N, Núñez-Vasco J, et al. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav Immun. 2014;36:111–7.

Article  PubMed  Google Scholar 

Zhou XY, Thai M, Roediger D, Mueller BA, et al. Mitochondrial health, NLRP3 inflammasome activation, and white matter integrity in adolescent mood disorders: a pilot study[. J] J Affect Disord. 2023;340:149–59.

Article  CAS  PubMed  Google Scholar 

Ariel A, Serhan C. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007;28(4):176–83.

Article  CAS  PubMed  Google Scholar 

Serhan C, Chiang N, Dalli J. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Mol Aspects Med. 2018;64:1–17.

Article  CAS  PubMed  Google Scholar 

Bannenberg G, Serhan C. Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim Biophys Acta. 2010;1801(12):1260–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lamon-Fava S, So J, Mischoulon D, Ziegler T, et al. Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. Prostaglandins Leukot Essent Fat Acids. 2021;164:102219.

Article  CAS  Google Scholar 

Kok Kendirlioglu B, Unalan Ozpercin P, Yuksel Oksuz O, Sozen S, et al. Resolvin D1 as a novel anti-inflammatory marker in manic, depressive and euthymic states of bipolar disorder. Nord J Psychiatry. 2020;74(2):83–8.

Article  PubMed  Google Scholar 

Deyama S, Ishikawa Y, Yoshikawa K, Shimoda K, et al. Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like behaviors through the mTORC1 Signaling Pathway. Int J Neuropsychopharmacol. 2017;20(7):575–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishikawa Y, Deyama S, Shimoda K, Yoshikawa K, et al. Rapid and sustained antidepressant effects of resolvin D1 and D2 in a chronic unpredictable stress model[. J] Behav Brain Res. 2017;332:233–6.

Article  CAS  Google Scholar 

Chen JJ, Chen J, Jiang ZX, Zhou Z, Zhou CN. Resolvin D1 alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 signaling pathway. J Biol Regul Homeost Agents. 2020;34(5).

Wei C, Guo S, Liu W, Jin F, et al. Resolvin D1 ameliorates inflammation-mediated blood-brain barrier disruption after subarachnoid hemorrhage in rats by modulating A20 and NLRP3 inflammasome. Front Pharmacol. 2020;11:610734.

Article  CAS  PubMed  Google Scholar 

Cipriani A, Zhou X, Del Giovane C, Hetrick S, et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet (London England). 2016;388(10047):881–90.

Article  CAS  PubMed  Google Scholar 

Prüss H, Rosche B, Sullivan A, Brommer B, et al. Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial. PLoS ONE. 2013;8(2):e55859.

Article  PubMed  PubMed Central  Google Scholar 

Szczuko M, Kotlęga D, Palma J, Zembroń-Łacny A, et al. Lipoxins, RevD1 and 9, 13 HODE as the most important derivatives after an early incident of ischemic stroke. Sci Rep. 2020;10(1):12849.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morris T, Stables M, Colville-Nash P, Newson J, et al. Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways. Proc Natl Acad Sci USA. 2010;107(19):8842–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Köhler-Forsberg O, Buttenschøn H, Tansey K, Maier W, et al. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain Behav Immun. 2017;62:344–50.

Article  PubMed  Google Scholar 

Tao W, Hu Y, Chen Z, Dai Y, et al. Magnolol attenuates depressive-like behaviors by polarizing microglia towards the M2 phenotype through the regulation of Nrf2/HO-1/NLRP3 signaling pathway. Phytomedicine: Int J Phytotherapy Phytopharmacology. 2021;91:153692.

Article  CAS  Google Scholar 

Enache D, Pariante C, Mondelli V. Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun. 2019;81:24–40.

Article  PubMed  Google Scholar 

Gabbay V, Klein R, Guttman L, Babb J, et al. A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression. J Child Adolesc Psychopharmaco